| Literature DB >> 28050676 |
Takashi Aoyama1, Osamu Imataki2, Keita Mori3, Kanako Yoshitsugu4, Masafumi Fukaya4, Ikue Okamura4, Terukazu Enami4, Raine Tatara4, Takashi Ikeda5.
Abstract
Hematopoietic stem cell transplantation carries nutrition-related risks. Therefore, nutritional therapy needs to be initiated before transplantation even takes place. We assessed nutritional risk among patients who underwent allogeneic stem cell transplantation. We assessed nutrient supply (calorie supply and protein supply) by chart review. Assessments were made from the pretreatment phase of transplantation to after the end of parenteral nutrition in 51 patients who underwent allogeneic stem cell transplantation at Shizuoka Cancer Center between 2007 and 2012. We compared nutrition-related adverse events and parameters between two groups: those in whom % loss of body weight was ≥7.5 and those in whom % loss of body weight was <7.5. A correlation was observed between changes in weight and skeletal muscle mass (r = 0.89; P < 0.0001). A weak correlation was observed between % loss of body weight and nutrient supply of calories (r = 0.517; P = 0.0001). There were significant differences between the % loss of body weight ≥7.5 group and the % loss of body weight <7.5 group in the following variables: % loss of body weight, nutrient supply from calories and protein; orally ingested nutrient supply from calories and protein; start day of oral intake; and acute graft-versus-host disease. Orally ingested calories were negatively correlated with nutrition-related adverse events in both groups. Early and customized nutritional intervention may be optimal for all patients who undergo allogeneic stem cell transplantation to ameliorate body weight loss associated with nutrition-related adverse events.Entities:
Keywords: Allogeneic blood stem cell transplantation; Bioelectrical impedance analysis; Nutrition-related adverse events; Nutritional pathway
Mesh:
Year: 2017 PMID: 28050676 DOI: 10.1007/s00277-016-2910-9
Source DB: PubMed Journal: Ann Hematol ISSN: 0939-5555 Impact factor: 3.673